Full Guideline: Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline
JCEM June 2012
Nelson B. Watts, Robert A. Adler, John P. Bilezikian, Matthew T. Drake, Richard Eastell, Eric S. Orwoll, Joel S. Finkelstein
Objective:
The aim was to formulate practice guidelines for management of osteoporosis in men.
Conclusions:
- Osteoporosis in men causes significant morbidity and mortality.
- We recommend testing higher risk men [aged ≥70 and men aged 50–69 who have risk factors (e.g. low body weight, prior fracture as an adult, smoking, etc.)] using central dual-energy x-ray absorptiometry.
- Laboratory testing should be done to detect contributing causes.
- Adequate calcium and vitamin D and weight-bearing exercise should be encouraged; smoking and excessive alcohol should be avoided.
- Pharmacological treatment is recommended for men aged 50 or older who have had spine or hip fractures, those with T-scores of −2.5 or below, and men at high risk of fracture based on low bone mineral density and/or clinical risk factors.
- Treatment should be monitored with serial dual-energy x-ray absorptiometry testing.
Read the Full Guideline
